Market Place
Sourcing Support
Novartis` asciminib bests Pfizer`s Bosulif in phase 3 leukemia trial
27 Aug 2020 //
FIERCE BIOTECH
EMA’s CHMP Recommends Five New Medicines for Approval
26 Feb 2018 //
RAPS
First-line use of Pfizer’s Bosulif cleared in the US
21 Dec 2017 //
PHARMA TIMES
Pfizer, Avillion file for Bosulif expansion
31 Aug 2017 //
PHARMA TIMES
Pfizer`s Ibrance faces tough review at NICE, U.K. exec worries
28 Nov 2016 //
FIERCE PHARMA
Eisai Latest Cancer Drugmaker to Win UK Approval After Price Cut
03 Nov 2016 //
REUTERS
Pfizer’s Bosulif wins NICE backing after new discount offer
07 Jul 2016 //
FIERCE PHARMA
BCR-ABL Tyrosine Kinase Inhibitors - Risk of Hepatitis B Reactivation
06 May 2016 //
HEALTH CANADA
Health Canada Require Updated Warning on Gleevec Labeling for Brand and Generics
05 May 2016 //
TWOFOUR INSIGHT
NHS watchdog takes issue with Pfizer exec`s role on foundation trust`s board
20 Jan 2016 //
FIERCE PHARMA
Twenty-three therapies axed from Cancer Drugs Fund
08 Sep 2015 //
PHARMATIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.